Sanofi Toronto Facility Update Regarding ImmuCyst

by Health Canada on July 11, 2012

in Canadian Recalls,Health Canada Recalls

Health Canada has completed a thorough health risk assessment of the bladder cancer treatment ImmuCyst produced at Sanofi Pasteur’s manufacturing plant in Toronto.

This is a summary of a recall issued by Health Canada. The link below will take you to the original recall press release containing complete information, including instructions about what to do if you are affected by this recall.

View Full Details Of Original Health Canada Recall Notice Here

Leave a Comment

Previous post:

Next post: